WinnPB,,,,in the video MD refers to these previous announcements;

Oct. 29, 2018 Bioasis Announces xB3 ™ Platform Technology Licensing Agreement with Prothena

And the:

• Jan. 7, 2019 Bioasis Announces Agreement With Leading Pharmaceutical Company for Pre-Clinical Research Using the xB3 Platform Technology

  Under the terms of the Material Transfer Agreement, Bioasis will receive $500,000.

   

  Most likely our share price is stuck here at the moment cuz some of the PP shares are being sent to market so that their warrants would be are almost free, and thus little skin in the play until there is concrete data returned!!

Time will tell,,,there is lots of work going on in the background away from prying eyes is my guess,,,,2019 might turn out to be very special for us!!,,,,one can never say never unless a fella can get a hold of an end of the year newspaper tomorrow!!,,and we know that just aint going to happen!